Acelrx Pharmaceuticals Inc

+0.02 (+2.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)91.75M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.4 Million
Adjusted EPS-$0.05
See more estimates
10-Day MA$0.68
50-Day MA$0.89
200-Day MA$1.26
See more pivots

Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX

25821 Industrial Boulevard, Suite 400, Hayward, California 94545
United States of America
Phone: +1.650.216.3500
Number of Employees: 54


AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.